Utility of a mainstreamed genetic testing pathway in breast and ovarian cancer patients during the COVID-19 pandemic

INTRODUCTION: Mainstreamed genetic testing (MGT) obviates the need for a cancer genetics consultation, since trained oncologists (O) and gynaecologists (G) provide counseling, prescribe testing and deliver results. We report results from our MGT program and emphasize its utility during the COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Benusiglio, Patrick R., Korenbaum, Clément, Vibert, Roseline, Ezenfis, Joël, Geoffron, Sophie, Paul, Charlotte, Richard, Sandrine, Byrde, Veronique, Lejeune, Manon, Guillerm, Erell, Basset, Noemie, Lotz, Jean-Pierre, Chabbert-Buffet, Nathalie, Gligorov, Joseph, Coulet, Florence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654320/
https://www.ncbi.nlm.nih.gov/pubmed/33186762
http://dx.doi.org/10.1016/j.ejmg.2020.104098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654320/
https://www.ncbi.nlm.nih.gov/pubmed/33186762
http://dx.doi.org/10.1016/j.ejmg.2020.104098

Ejemplares similares